OptiMAL in Biological Technology

New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance

OAKLAND, Calif., Dec. 12 /PRNewswire/ -- LUMEDX Corporation, the market leader in providing fully integrated cardiovascular information and imaging solutions, introduces CardioManager Performance Management System(TM), cardiology software that translates complex data -- clinical, operational, ...

National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment

Genzyme Genetics to Provide Testing for Important Cancer and Leukemia Group B Study WESTBOROUGH, Mass., Dec. 4 /PRNewswire-FirstCall/ -- Genzyme Genetics, a business unit of Genzyme Corporation (Nasdaq: GENZ ), announced today its participation in a Cancer and Leu...

FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses

By Brian Schlag and John Dunlop of Neuroscience Discovery Research, Wyeth Research, CN-8000, Princeton, NJ 08543. SUPERIOR PERFORMANCE HIGHER THROUGHPUT IMPROVED DATA QUALITY RESCUES SUB-OPTIMAL ASSAYS ...

Determining the Signal-to-Noise Ratio and Optimal Photomultiplier gain setting in the GenePix 4000B

Siobhan Pickett, M.S., Sean Carriedo, Ph.D. and Chang Wang, Ph.D. Axon Instruments, Inc. 3280 Whipple Road, Union City, CA 94587 Last updated: September 13, 2001 Introduction An important criterion for comparing the perf...

Select the Optimal Enzyme for RT-PCR

A major factor to consider in reverse transcription polymerase chain reaction (RT-PCR) is the choice of the appropriate reverse transcriptase. Roche Applied Science has developed and optimized a wide variety of different ...

Find the optimal product for your application

Roche Applied Science (RAS) provides an extensive product line for amplification. For a quick overview you can browse through the Product Overview . Although all products will perform in a broad array of applications, we wou...

Find the optimal product for your PCR application

Which of the following statements best describes your template/starting material: ...

An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat

Dr. Frank Stahl GBF Gesellschaft fr Biotechnologische Forschung mbH (Society for Biotechnological Research) Introduction DNA microarrays are a key technology in modern molecular biotec...

Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast

...fers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any ...

Rapid heating prepares energy-saving zeolite for greater role in industrial separations

...ed for the industrial separations of molecules and mixtures, often in volatile, energy-hungry distillation towers. By contrast, zeolite membranes with optimal porosity consume much less energy when they perform separations. When zeolites are made, structure directing agents, or SDAs, direct the formation ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...f our NDA. Looking ahead, we intend to design a study that complies with the new draft CAP guidance and we will work with the Agency to determine the optimal pathway to registration." Dr. Flavin continued, "We remain encouraged by the supportive comments made by AIDAC committee members in June relat...

Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call

...inflammatory diseases and cancer. The Company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's current product candidates are novel single-chain ...

Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

...ere similar for both the 150 mg and 250 mg doses of elagolix and, given the superior bone safety profile, the 150 mg once daily dose appears to be the optimal choice for upcoming Phase III trials." There were no signals of dose limiting adverse events or changes in clinical chemistry, hematology, uri...

Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting

...s. "No two patients and no two tumors are alike. We are committed to providing clinicians with the flexibility and the tools they need to choose the optimal treatment approach for each and every patient, and then deliver that treatment." Varian will also exhibit other products and capabilities at ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...phase where they were randomized into two groups. One group received their optimal dose of Vyvanse the first week and placebo the second week. The second group received placebo the first week and their optimal dose of Vyvanse the second week. The primary objective of this stu...

Heart disease: Research off the beating patch

...think the main reason for the disappointing results people have seen with those clinical trials is that the cells end up in an environment that is not optimal for them to thrive in. Scar tissue offers poor blood supply and weak structural support for new cells to attach, survive and grow. Our patch offers ju...

LS9's UltraClean Diesel Exceeds United States & Brazilian Fuels Specifications

... such as benzene and only trace amounts of sulfur. LS9's technology also makes it possible to create superior products that can uniquely achieve optimal overall performance. LS9 has demonstrated its ability to modify the genetic makeup of its microorganisms and precisely tailor LS9 end products to hav...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

...ncer. "We are excited to work with this innovative technology that enables us to move SG410 into Biomerk Tumorgraft testing and determine its optimal clinical application," said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. "We expect to have early Biomerk Tumorgraft results for SG...

NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling

... personnel are spending a great deal of time gathering requests, creating schedules, and cycling through multiple iterations trying to meet all needs. optimal and equitable schedules are not always achieved. There's a clear opportunity to assist physicians and administrative staff in building schedules that ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...of IMRT II-44 Androgen Deprivation Therapy (ADT) II-44 High Dose Radiation (HDR) Monotherapy II-45 Drawbacks of HRD II-45 Choosing the optimal Treatment Method II-45 Recurrent Prostate Cancer II-46 Recurrent Prostate Cancer Subsequent to Surgery II-46 Recurrent Prostate Cancer Sub...

Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome

...o are symptomatic despite treatment with currently available therapy. Up to four dose levels may be evaluated in a serial ascending fashion. Once an optimal or maximal dose is identified, additional patients will be added to confirm clinical observations. "The clinical trial will be conducted at multi...

Unisense FertiliTech A/S Receives CE Mark of Approval for EmbryoScope(TM) Embryo Monitoring System

... embryologist must select the best potential embryo or embryos to transfer to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to maternal and fetal health. A major challenge for the embryologist is determining which embryos have th...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

...g, compared to placebo in 142 adults with ADHD using the adult simulated workplace environment setting. A four-week, open-label phase to identify the optimal dose preceded the two-week double-blind phase in which efficacy was evaluated. The primary efficacy measure of the study was the average of postd...

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer

...isions," said Dr. Joseph Gligorov, Tenon Hospital, Paris. "More patients for whom the prognostic evaluation is still uncertain with the classical and optimal pathological tools, should now be offered the opportunity to benefit from these new tests, as it provides both physicians and patients with valuable, ...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

...inflammatory diseases and cancer. The Company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's current product candidates are novel single-chain ...

Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center

...Le, Medical Director of the St. John Wound Center. "We work closely with specialists and primary care physicians to provide a complete care plan for optimal wound healing to address the specific needs of each patient." All ETC BioMedical monoplace chambers include O.S.C.A.R. (TM) (Operating System fo...

Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award

...ure directly beneath the patient. The product also offers PressureSmart(TM) Sensing Technology that senses the patient position in real time, allowing optimal pressure redistribution as the patient sleeps, turns, sits up and gets out of bed. The Medical Design Excellence Awards competition, organized a...

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

...n and preservation of blood flow, allowing for capture of clinically significant clot and protection against PE. The self-centering filter facilitates optimal positioning and stability within the inferior vena cava. About Pulmonary Embolism (PE) PE is an extremely common and highly lethal condition...

Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler

...atol Surg 2008; 34; S31-S39 * Initial treatment is defined as a single treatment with the option of touch-up within two to three weeks to achieve optimal correction. About Ortho Dermatologics: EVOLENCE(R) is marketed in the United States by Ortho Dermatologics division of Ortho-McNeil-Janssen...

Researchers solve 'bloodcurdling' mystery

...e trimmed in size. The system is so finely tuned that the A2 shear sensor is able to regulate the size of VWF within the blood stream, maintaining the optimal size for responding properly to traumas," says Wong. To make the discovery, the team relied upon an "optical tweezers" system developed in Wong's l...

Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners

... Investment Positions optimal for Expansion in Medical Imaging Management For...oups BIRMINGHAM, Ala., June 4 /PRNewswire/ -- optimal Reading Services Group, Inc., a US-based, leading ...ial investment in Optimal. The investment provides optimal with funds to accelerate its expansion throughout ...

PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting

...h #1701. A global team of PAREXEL experts will be available for on-site exclusive executive briefings and to discuss the Company's model for achieving optimal efficiency and effectiveness in clinical development. These experts will also address partnering best practices, including strategic guidance and crea...

Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays

...platform allows for the walk-away automation of the entire FISH assay workflow, from specimen pretreatment to final cover-slipping and is designed for optimal results with Abbott Molecular AutoFISH(TM) reagents and FISH technology. The Xmatrx will be co-branded and marketed under a co-exclusive distribu...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

...phase where they were randomized into two groups. One group received their optimal dose of VYVANSE the first week and placebo the second week. The second group received placebo the first week and their optimal dose of VYVANSE the second week. The primary objective of this study w...

Roche Announces Back-to-Basics Approach to Diabetes Care - Simpler is Better

...ith diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions...

Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg

...IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit. "We're extremely excited to continue with the global expansion of our distribution strategy for the VerifyNow System. Accumetrics has c...

Agendia Opens CLIA-Registered U.S. Genomics Laboratory

... "Our new genomics lab's capacity will allow us to meet the increasing demand for MammaPrint across the United States and give physicians and patients optimal test result turnaround and unmatched service and support," noted Jan Groen, Ph.D., Chief Operating Officer. "This expansion places us in an excellent ...

Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals

...therapeutics. Beactica's Sprint(TM) drug discovery platform efficiently integrates surface plasmon resonance (SPR) to accelerate the identification of optimal starting points and development routes for lead discovery. The company was spun out of Uppsala University in August 2006. As well as building collab...

Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting

...inflammatory diseases and cancer. The Company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's current product candidates are novel single-chain ...

YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

... AeroLEF(R), for further development internationally. After consulting with regulatory bodies in Europe and Canada, the Company is now determining the optimal clinical path forward and conducting discussions with potential partners. Financial Results (CDN dollars) Total revenue (out-licensing reven...